Neurogene Inc. (NASDAQ: NGNE)
$36.4200
-35.1000 ( -49.10% ) 823.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$36.4200
Previous close
$71.5300
Volume
823.0K
Market cap
$582.62M
Day range
$36.3150 - $49.5450
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 3 | Insider transactions | 2 | Dec 26, 2023 |
| 4 | Insider transactions | 1 | Dec 20, 2023 |
| 8-k | 8K-related | 41 | Dec 19, 2023 |
| 8-k | 8K-related | 12 | Dec 06, 2023 |
| 8-k | 8K-related | 13 | Dec 04, 2023 |
| 10-q | Quarterly Reports | 51 | Nov 14, 2023 |